Characterization of the effect of sample quality on high density oligonucleotide microarray data using progressively

Karol L Thompson1, P Scott Pine, Barry A Rosenzweig

  • 1Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. karol.thompson@fda.hhs.gov

BMC Biotechnology
|September 15, 2007
PubMed
Abstract

Related Concept Videos